Skip to content

Strategies for Implementing a Postpartum Lifestyle Intervention in WIC Clinics

Strategies for Implementing a Postpartum Lifestyle Intervention in WIC Clinics: A Cluster Randomized Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06116149
Acronym
STRIVE
Enrollment
722
Registered
2023-11-03
Start date
2023-12-12
Completion date
2027-04-30
Last updated
2025-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational Diabetes, Glucose Intolerance During Pregnancy, Hyperglycemia, Lifestyle, Healthy, Obesity, PreDiabetes

Keywords

Diabetes Prevention Program

Brief summary

The primary objective of the STRIVE study is to compare two implementation strategies for Diabetes Prevention Program delivery: an in-person health coach strategy (standard 24 in-person sessions at WIC clinics) vs. a multifaceted technology-assisted health coach implementation strategy (12 in-person sessions at WIC clinics supplemented by technology support) on implementation and health-related outcomes in postpartum women.

Detailed description

The overall objective of this project is to study the implementation, effectiveness, and sustainability of implementing the Diabetes Prevention Program (DPP) in postpartum women who receive services from WIC. In this effectiveness-implementation type III cluster-randomized trial, we will compare two implementation strategies for DPP delivery: an in-person health coach-led implementation strategy (standard 24 in-person sessions) vs. a multifaceted technology-assisted health coach implementation strategy (12 in-person sessions supplemented by technology tools). Nineteen clinics will be randomized to the multifaceted technology-assisted health coach strategy and 19 to the in-person health coach-led strategy. A total of 722 postpartum participants (19 per clinic) will be recruited into the study and followed for 12 months for implementation and effectiveness outcomes. A post-intervention study visit will take place 6 months after the end of the 12-month intervention to evaluate the sustainability of the implementation strategies.

Interventions

BEHAVIORALIn-person health coach delivery of the GLB

Delivery of 24 health coaching sessions in-person by health coaches over 1 year. Standard delivery of 24-sessions of the Group Lifestyle Balance (GLB) behavioral intervention in WIC clinics. The GLB was adapted from the original Lifestyle Balance behavioral intervention used in the original Diabetes Prevention Program trial for use in community translation and group settings. It focuses on improving diet and physical activity and promoting moderate weight loss through health coaching on behavioral change, including self-monitoring of food intake, physical activity, and weight.

BEHAVIORALTechnology-assisted health coach delivery of the GLB

Delivery of 12 health coaching GLB sessions in-person by health coaches over one year; supplemental technology support, including tools for self-monitoring, health coach monitoring, asynchronous delivery of intervention materials, and asynchronous coach and group connection. The GLB was adapted from the original Lifestyle Balance behavioral intervention used in the original Diabetes Prevention Program trial for use in community translation and group settings. It focuses on improving diet and physical activity and promoting moderate weight loss through health coaching on behavioral change, including self-monitoring of food intake, physical activity, and weight.

Sponsors

National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
Pennington Biomedical Research Center
CollaboratorOTHER
University of Pennsylvania
CollaboratorOTHER
Tulane University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Masking description

Due to the nature of the cluster design and intervention program, the study participants, health coaches, DPP Coordinators, WIC clinic staff, and research staff who collect clinical outcome data will not be blinded.

Intervention model description

Cluster-randomization of 38 Women, Infants, and Children (WIC) clinics

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

for Clinics: * Serve a large number of WIC postpartum participants * Willing and able to provide space for the study Inclusion Criteria for Participants: * Age 18 or older * Gave birth in the past 6 weeks to 12 months * Obesity or history of gestational diabetes mellitus (Current BMI ≥30 kg/m², OR Medical-record documented history of gestational diabetes mellitus and BMI ≥25 kg/m²) * No self-reported diabetes (other than gestational diabetes) * Hemoglobin A1c \<6.5% * Not currently pregnant or planning to become pregnant in the next 6 months * No plans to move outside of the study region in the next 12 months * Access to a smartphone * Willing and able to participate in the intervention and provide consent * Not an immediate family member of the staff at the WIC clinic * Other concerns regarding ability to meet trial requirements, at the discretion of the principal investigator or study coordinator

Design outcomes

Primary

MeasureTime frameDescription
Difference in mean 12-month weight reduction (primary health-related outcome)Measured at 3, 6, 9 and 12 monthsThe primary health-related outcome will be difference in mean weight reduction from baseline to 12 months between study arms
Difference in uptake (primary implementation outcome)Measured from baseline to 12 monthsThe primary implementation outcome will be the difference between study arms in a composite uptake score, as defined by a composite score consisting of the percent of sessions attended and the percentage of times in which participants record weight, activity, and diet compared to what is recommended by the intervention.

Secondary

MeasureTime frameDescription
AcceptabilityMeasured at baseline, 6, and 12 monthsAcceptability scores for participants, DPP coordinators, DPP coaches, WIC clinic management. Measured by survey; higher score means better outcome.
AppropriatenessbaselineAppropriateness scores for participants, DPP coordinators, DPP coaches, WIC clinic management. Measured by survey; higher score means better outcome.
Feasibility (suitability)BaselineFeasibility scores for participants, DPP coordinators, DPP coaches, and WIC clinic management. Measured by survey; higher score means better outcome.
Adoption (WIC clinics)BaselinePercentage of invited WIC clinics adopting the DPP program. Measured by study administrative data.
Adoption (WIC nutritionists)BaselinePercentage of invited WIC nutritionists being trained. Measured by study administrative data.
Adoption (WIC health educators)BaselinePercentage of invited WIC health educators being trained. Measured by study administrative data.
Penetrance (participants)12 monthsPercentage of enrolled participants receiving assigned intervention. Measured by study administrative data.
Penetrance (WIC DPP coordinators)12 monthsPercentage of percentage of trained WIC DPP coordinators supporting health coaches. Measured by study administrative data.
Penetrance (WIC health coaches)12 monthsPercentage of percentage of trained WIC DPP health coaches delivering the intervention. Measured by study administrative data.
Cost-effectiveness12 monthsIncremental direct costs (intervention) per additional percentage of individuals reaching weight loss goal at 12 months
Difference in mean 12-month change in percent weight reductionMeasured from baseline to 12 monthsDifference in mean percent weight reduction from baseline to 12 months between study arms
Difference in mean 12-month change in physical activityMeasured from baseline to 12 monthsDifference in mean change in physical activity from baseline to 12 months between study arms, as assessed by metabolic equivalent (MET)-h/week (measured by validated questionnaire)
Difference in mean 12-month change in healthy eating indexMeasured from baseline to 12 monthsDifference in mean change in healthy eating index from baseline to 12 months between study arms, as assessed by 24-hour dietary recalls (range 0 to 100; higher scores mean healthier eating pattern)
Difference in mean 12-month change in waist circumferenceMeasured from baseline to 12 monthsDifference in mean change in waist circumference from baseline to 12 months between study arms
Difference in mean 12-month change in hemoglobin A1cMeasured from baseline to 12 monthsDifference in mean change in hemoglobin A1c from baseline to 12 months between study arms
Difference in mean 12-month change in systolic blood pressureMeasured from baseline to 12 monthsDifference in mean change in systolic blood pressure from baseline to 12 months between study arms
Difference in mean 12-month change in diastolic blood pressureMeasured from baseline to 12 monthsDifference in mean change in diastolic blood pressure from baseline to 12 months between study arms
Difference in mean 12-month change in health-related quality of life (HRQoL)Measured from baseline to 12 monthsDifference in mean change in health-related quality of life (HRQoL) from baseline to 12 months between study arms (assessed by short form (SF)-12, validated survey)
Difference in proportion of participants meeting intervention goals at 12 monthsMeasured from baseline to 12 monthsAssessed by validated questionnaires, 24-hour dietary recalls, and weight measurements
Percentage of participants who were either eligible, screened, or contacted who were enrolled.BaselineReach
Fidelity12 monthsPercentage of sessions held

Other

MeasureTime frameDescription
Sustainability (DPP coordinators): comparison of perceived sustainability of the two implementation strategies among WIC staff18 monthsAssessed by surveys and interviews
Sustainability (Participants): comparison of the proportion of participants maintaining DPP goals at six months after their participation in the DPP has ended18 monthsAssessed by validated questionnaires, 24-hour dietary recalls, and weight measurements

Countries

United States

Contacts

Primary ContactTara Dobson, BA
tdobson@tulane.edu504.988.9922
Backup ContactKirsten Dorans, ScD
kdorans@tulane.edu504.988.0883

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026